Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.6.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.6.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.6.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.6.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FK.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FK.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FK.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used